Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Metabolic Reprogramming in Myelodysplastic Syndromes

Aikaterini Poulaki, Theodora Katsila, Emilia S Hatziyannis, Ioanna E Stergiou, Efstathia Kapsogeorgou, Stamatios Hatzis, George Vassilopoulos, Michael Voulgarelis, Stavroula Giannouli

Blood (2024) 144 (Supplement 1): 6694.

https://doi.org/10.1182/blood-2024-211216

Published: 2024

Journal Articles

The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts

Aikaterini Poulaki, MD, Theodora Katsila, PhD, Ioanna E Stergiou, MD, Stavroula Giannouli, MDPhD, Jose Carlos Gόmez Tamayo, Konstantinos Kambas, PhD, George Patrinos, PhD, George Vassilopoulos, MD PhD, Michael Voulgarelis, MD PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-140468

Published: 2020

Journal Articles

Prognostic Significance of Severe Thrombocytopenia in Overall Survival of Patients with Myelodysplastic Syndromes Treated with Azacytidine. a Multicenter Study By the Hellenic MDS Study Group

Athanasios Galanopoulos, MD PhD, Evdoxia Kamouza, Christos K. Kontos, PhD, Argiris Symeonidis, MD PhD, Vassiliki Pappa, MD, Alexandra Kourakli, MD PhD, Nora-Athina Viniou, MD, Sotirios Papageorgiou, MD PhD, Charalampos Pontikoglou, Menelaos Konstantinos Papoutselis, Helen A. Papadaki, MD PhD, Eleftheria Hatzimichael, Panagiotis Zikos, Dr, Maria Dimou, Panayiotis Panayiotidis, MD PhD, Dimitrios Tsokanas, Despina Mparmparousi, Flora Kontopidou, Eleni Variami, Panagiotis Repousis, MD, Elias Poulakidas, Dimitrios Christoulas, MD, Theodoros Vassilakopoulos, MDPhD, Michael Voulgarelis, MD PhD, Aikaterini Megalakaki, Maria Kotsopoulou, Giorgos Karianakis, Despina Kaliontzi, Ioannis Adamopoulos, MD, Maria Dalekou, Anastasia Sioni, Maria Papaioannou, Dimitrios Gogos, Panagiotis Theodorou Diamantopoulos, MD PhD, Elena E. Solomou, MD, Ioannis Kotsianidis, PhD

Blood (2018) 132 (Supplement 1): 1822.

https://doi.org/10.1182/blood-2018-99-119531

Published: 2018

Journal Articles

Autophagy in Myelodysplastic Syndromes: The Role of HIF-1a/REDD1 Molecular Pathway

Ioanna Stergiou, MD, Konstantinos Kambas, PhD, Stavroula Giannouli, MDPhD, Theodora Katsila, PhD, Aglaia Dimitrakopoulou, MD, Veroniki Vidali, PhD, Evgenia Synolaki, Aristea Papageorgiou, MDPhD, Andrianos Nezos, PhD, George Patrinos, PhD, Paschalis Sideras, PhD, Konstantinos Ritis, MDPhD, George Vassilopoulos, MD PhD, Athanasios Tzioufas, MDPhD, Michael Voulgarelis, MD PhD

Blood (2018) 132 (Supplement 1): 1808.

https://doi.org/10.1182/blood-2018-99-112813

Published: 2018

Journal Articles

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Argiris Symeonidis, MD PhD, Alexandra Kourakli, MD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, Eleftheria Hatzimichael, Theodoros Vassilakopoulos, MDPhD, Aikaterini Palla, Vassiliki Pappa, MD, Evgenia Verigou, Zafeirios Kartasis, MD, Eirini Katodritou, Maria Pagoni, Theodora Assimakopoulou, Charalampos Pontikoglou, MD PhD, Maria Dimou, George Xanthopoulidis, Maria K. Angelopoulou, MD, Maria Kotsopoulou, Dimitra Liapi, Despina Mparmparousi, Evridiki Michali, Anna Kioumi, Nora-Athina Viniou, Achilles Anagnostopoulos, Vassiliki Labropoulou, Maria Dalekou, Michael Voulgarelis, MD PhD, Efthymia Vlachaki, Anna Christoforidou, Ioannis Adamopoulos, MD, Akrivi Kostourou, Petros Laos, Evangelos Terpos, MD PhD, Eleni Kapsali, George Vassilopoulos, MD PhD, Helen A. Papadaki, MD PhD, Panayiotis Panayiotidis, MD PhD, Athanasios Galanopoulos, MD PhD

Blood (2017) 130 (Supplement 1): 1696.

https://doi.org/10.1182/blood.V130.Suppl_1.1696.1696

Published: 2017

Journal Articles

Competing Risk Survival Analysis In Patients With Symptomatic Waldenström’s Macroglobulinemia (WM): Disease Unrelated Mortality Accounts For Differences In Survival In Patients >75 Years

Efstathios Kastritis, Marie-Christine Kyrtsonis, MD, Evdoxia Hatjiharissi, Argiris S. Symeonidis, Amalia Vassou, Panagiotis Repousis, Sosana Delimpasi, Anastasia Sioni, Eurydiki Michalis, Michalis Michael, Elina Vervessou, Ekaterini Stefanoudaki, Michael Voulgarelis, Costas Tsatalas, Evangelos Terpos, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3197.

https://doi.org/10.1182/blood.V122.21.3197.3197

Published: 2013

Journal Articles

No Significant Improvement In the Outcome of Patients with Waldenström's Macroglobulinemia Treated Over the Last 25 Years

Blood (2010) 116 (21): 3032.

https://doi.org/10.1182/blood.V116.21.3032.3032

Published: 2010

Journal Articles

The International Scoring System (ISS) for Multiple Myeloma Remains a Robust Prognostic Tool Independently of Patients' Renal Function

Blood (2010) 116 (21): 3036.

https://doi.org/10.1182/blood.V116.21.3036.3036

Published: 2010

Journal Articles

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's Macroglobulinemia (WM) and the Importance of Serum Lactate Dehydrogenase (LDH).

Blood (2009) 114 (22): 2845.

https://doi.org/10.1182/blood.V114.22.2845.2845

Published: 2009

Journal Articles

Cardiac Magnetic Resonance Imaging Detects Long-Term Fibrotic Changes in Patients with Primary Eosinophilic Disorders: A Cross-Sectional Study

Issa J. Dahabreh, Stavroula Giannouli, Sofia Mavrogeni, Haralampos M. Moutsopoulos, Michael Voulgarelis

Blood (2008) 112 (11): 5236.

https://doi.org/10.1182/blood.V112.11.5236.5236

Published: 2008

Journal Articles

No Evidence for Increased Prevalence of JAK2 V617F in Women with a History of Recurrent Miscarriage

Issa J. Dahabreh, Amy V. Jones, Michael Voulgarelis, Christina Alafakis-Tzannatos, Stavroula Giannouli, Marighoula Varla-Leftherioti, Theodora Keramitsoglou, Christine Zoi, Dimitris Loukopoulos, Stelios Fotiou, Nicholas C.P. Cross, PhD, Katerina Zoi, PhD

Blood (2008) 112 (11): 5235.

https://doi.org/10.1182/blood.V112.11.5235.5235

Published: 2008

NARROW

Metabolic Reprogramming in Myelodysplastic Syndromes

The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts

Prognostic Significance of Severe Thrombocytopenia in Overall Survival of Patients with Myelodysplastic Syndromes Treated with Azacytidine. a Multicenter Study By the Hellenic MDS Study Group

Autophagy in Myelodysplastic Syndromes: The Role of HIF-1a/REDD1 Molecular Pathway

Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome

Competing Risk Survival Analysis In Patients With Symptomatic Waldenström’s Macroglobulinemia (WM): Disease Unrelated Mortality Accounts For Differences In Survival In Patients >75 Years

No Significant Improvement In the Outcome of Patients with Waldenström's Macroglobulinemia Treated Over the Last 25 Years

The International Scoring System (ISS) for Multiple Myeloma Remains a Robust Prognostic Tool Independently of Patients' Renal Function

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's Macroglobulinemia (WM) and the Importance of Serum Lactate Dehydrogenase (LDH).

Cardiac Magnetic Resonance Imaging Detects Long-Term Fibrotic Changes in Patients with Primary Eosinophilic Disorders: A Cross-Sectional Study

No Evidence for Increased Prevalence of JAK2 V617F in Women with a History of Recurrent Miscarriage

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only